Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Newron Pharmaceut.

Start price
Target price
Perf. (%)
€8.65
10.01.24
-
10.01.25
-6.36%
21.01.24

buy
Cellectar BioSciences Inc.

Start price
Target price
Perf. (%)
€3.70
08.01.24
-
08.01.25
-12.97%
20.01.24

buy
Cellectar BioSciences Inc.

Start price
Target price
Perf. (%)
€2.64
08.01.24
-
08.01.25
11.36%
14.05.24

buy
PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€4.62
07.01.24
-
07.01.25
-11.80%
20.01.24

Could be worthwhile Investment >10% per year
Newron Pharmaceut.

Start price
Target price
Perf. (%)
€6.95
04.01.24
-
04.01.25
34.53%
10.01.24

buy
Cellectar BioSciences Inc.

Start price
Target price
Perf. (%)
€2.74
03.01.24
-
03.01.25
-3.65%
06.01.24

Risky Investment
buy
PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€4.70
02.01.24
-
02.01.25
-1.70%
07.01.24

buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€17.00
28.12.23
€25.00
28.12.24
-20.33%
06.01.24

buy
PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€4.67
27.12.23
-
27.12.24
-1.07%
06.01.24

buy
AC Immune Ltd

Start price
Target price
Perf. (%)
€4.16
26.12.23
-
26.12.24
-8.05%
19.01.24

Could be worthwhile Investment >10% per year
buy
PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€4.54
10.12.23
-
10.12.24
2.98%
23.12.23

buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€13.80
10.12.23
€40.00
10.12.24
-19.13%
26.03.24

Could be very worthwhile Investment >20% year
Rising EBIT margin expected
High Investments for future growth
Very valuable balance sheet
CEL-SCI Corp.

Start price
Target price
Perf. (%)
€2.60
04.12.23
-
04.12.24
-6.15%
09.12.23

buy
Cellectar BioSciences Inc.

Start price
Target price
Perf. (%)
€2.34
02.12.23
€4.00
31.12.25
12.82%
07.01.24

Could be very worthwhile Investment >20% year
CytoTools AG

Start price
Target price
Perf. (%)
€1.05
01.12.23
-
01.12.24
-64.57%
13.05.24

Inotiv Inc.

Start price
Target price
Perf. (%)
€2.46
28.11.23
€0.000
28.11.24
26.83%
09.12.23

Risky Investment
EBIT decline > 20% expected
Decining EBIT margin than peer group
High valuation
buy
PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€5.50
26.11.23
-
26.11.24
-17.55%
09.12.23

buy
AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€2.03
26.11.23
-
26.11.24
-20.79%
26.12.23

Newron Pharmaceut.

Start price
Target price
Perf. (%)
€4.90
25.11.23
€2.00
25.11.24
-2.04%
09.12.23

Inotiv Inc.

Start price
Target price
Perf. (%)
€2.44
25.11.23
€1.00
25.11.24
27.87%
09.12.23

buy
PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€3.21
23.11.23
-
-
25.11.23

CEL-SCI Corp.

Start price
Target price
Perf. (%)
€2.60
15.11.23
-
15.11.24
-13.08%
24.11.23

CEL-SCI Corp.

Start price
Target price
Perf. (%)
€2.12
12.11.23
-
12.11.24
6.60%
25.11.23

Fuji Pharma Co. Ltd.

Start price
Target price
Perf. (%)
€8.90
11.11.23
€4.00
11.11.24
2.25%
25.11.23

PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€4.91
11.11.23
€2.00
11.11.24
12.13%
25.11.23